Is There a Difference?

Context In clinical pancreas transplantation the choice of preservation solution may have an impact on graft pancreatitis. Experience with histidine-tryptophan-ketoglutarate (HTK) is still limited whereas University of Wisconsin (UW) solution is currently the preferred perfusate worldwide. Objective The aim of this study was to analyze our experience with HTK in pancreas transplantation. Participants In a retrospective analysis, data from 95 primary simultaneous pancreas-kidney transplantations were reviewed. The use of HTK (n=48) and UW (n=47) solution was stratified into two groups. Main outcome measures Patient/graft survival and early graft function were compared. Results No significant differences between 1, 3 and 12 month patient survival (HTK